Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metformin in Parkinson's Disease: Safety and Efficacy
Sponsor: Jinnah Medical & Dental College
Summary
This study will evaluate whether metformin when it will be given to patients with Parkinson's disease along with standard therapy (levodopa carbidopa) will improve motor symptoms and decreases levels of alpha synuclein and MDA in patients with PD as compare to PD patients receiving only standard therapy (levodopa carbidopa)
Official title: Clinical Efficacy and Safety Profile of Metformin in Parkinson's Disease
Key Details
Gender
All
Age Range
50 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-08-28
Completion Date
2027-02-01
Last Updated
2026-09-09
Healthy Volunteers
No
Conditions
Interventions
Metformin 500mg
Metformin will be given to the group B along with the standard treatment